In addition, MECP2 sequencing and multiplex ligation-dependent probe amplification (MLPA) testing, Angelman syndrome MS-MLPA, and Fragile X (FMR1 PCR and Southern blot) testing were all normal. This evidence concerns the gene FMR1 and Angelman syndrome.